Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Terminated 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Neoplasms 1Constipation 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × naloxegol × Clear all
NCT03087708 2025-07-17

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Terminated
50 enrolled 24 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04219046 2020-07-28

ANTAGOCYST

Institut Paoli-Calmettes

Phase 2 Unknown
102 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02745353 2019-12-09

Naloxegol in Cancer Opioid-Induced Constipation

University of California, San Diego

Phase 2 Terminated
7 enrolled 9 charts
Other

Constipation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡